You are on page 1of 32

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition Toronto, Canada, October 5 - 6, 2006

Technology Transfer Challenges in Pharmaceutical Industry

Le Trong Vu, P. Eng. Manager, Validation Purdue Pharma

Agenda

Why Technology Transfer 2 Basic Concepts on How and When

3 Success Criteria 4 Thoughts on Keys to Success

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Why Technology Transfer

The development and transfer of knowledge and technology has been and will continue to be critical to success in pharmaceutical industry

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Why Technology Transfer

Stages in the Development of a New Medicine


Discovery

4 10 years
Research Target Biological Evaluation Integrated Research Candidate Drug Formulation Patents

Exploratory Development

3+ years
Formulation Development Process Development Phase I - Clinical Trials

Regulatory Development

3+ years
Manufacturing

Commercialization

3+ years

Registration Launch Sales

Phase II - Clinical Trials Phase III - Clinical Trials

Build/Select API Manufacturing Facilities

Built/Select Manufacturing Facilities

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Why Technology Transfer

When does technology transfer occur?


Idea to Discovery Lab Discovery Lab to Development Lab Development Lab to Kilo Lab Lab to Pilot Plant Kilo Lab to Pilot Plant Pilot Plant to Semi-works (other pilot plant) Pilot Plant/ Semi-works to Manufacturing Manufacturing to Manufacturing

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Why Technology Transfer

Technology Transfer Importance to Industry Process development and commercial production are on critical path because of compressed timeto-market expectations Technology Transfer is a vulnerable time for companies
Loss of knowledge or experience, leading to reinvention of the wheel Confused ownership and responsibilities Delayed approvals

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Stakeholders in the Quest for Effective Technology Transfer

Industry
R&D Commercial

Stakeholders
Regulators Customers
Patients Healthcare providers The public

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Stakeholders in the Quest for Effective Technology Transfer

Regulators roles:
Protect public health
Standardize regulations Ensure safe, pure, and effective drug products Drug approvals

Affect healthcare system


Facilitate and regulate, bringing new, more effective products to market faster Reduce the cost of healthcare

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Stakeholders in the Quest for Effective Technology Transfer

Industrys role:
Innovative R&D
Develop new, more effective compounds, delivery systems, and medical devices

Compliant and effective commercialization


Ensure safe, pure, and effective drug products Consistent interpretation of GMP regulations Bringing new, more effective products to market faster Adherence to all applicable regulations and guidelines Cost-effective production and distribution Superior return on investment to shareholders / stakeholders

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Stakeholders in the Quest for Effective Technology Transfer

Customers & Patients:


Safe and effective treatments New, more effective products to market faster Affordable healthcare cost Election of governments

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer A Paradigm Shift

Continuous Knowledge Transfer


Industrys Paradigm Shift
Continuous transfer of knowledge and technology Improved lifecycle management Good business practice Speed to market Globalization Advances the state-of-the-art
Project Conception Research and Development Commercial Operations Launch Involvement

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer A Paradigm Shift

Continuous Knowledge Transfer


Pre-Trials Phases II & III

Pre-IND

Highly interpretable regulations and guidelines Intermittent transfer of knowledge Reactive inspection and review practices
Involvement

IND

Project Conception Research and Development Commercial Operations

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

NDA PAI Post Approval

Regulatory Stakeholder Opportunities

Regs & Guidelines

Launch

Technology Transfer - How and When

Knowledge Transfer Process

Need an effective transfer process that plugs the leaks and yields better retention

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Then a miracle occurs

R&D Processes Commercial Operations

I think you need a few more details here in the Transfer protocol
Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer - How and When

ISPE Guide for Technology Transfer

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer - How and When

TT Guide is designed to:


Present standardized process Recommend minimal base of documentation to support the technical transfer process Define key terms and consistent interpretation Facilitate timely and cost effective technology transfers Consider regional requirements of US, Europe and Asia (Japanese Ministry of Health Labor and Welfare)

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer - How and When

TT Guide & Manufacturing Science


Encompasses Research, Development, Analytical, Process and Quality Guide focuses on the level, quality, and type of Information Enables the capture and sharing of the Right Knowledge

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer - How and When

Technology Transfer Task Relationships Model

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Success Criteria?

"You can tell pharmacy we finally have three batches of on-spec product."
Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

What Constitutes A Successful Technology Transfer?*


Success criteria from Definition of Technology Transfer: ability of a Receiving Unit to perform transferred technology, to the satisfaction of all parties and any, or all, applicable regulatory bodies Technology transfer can be considered successful if a Receiving Unit can routinely reproduce the transferred product, process or method against a predefined set of specifications as agreed with a Sending Unit and/or a Development Unit.
*From ISPE Technology Transfer Guide
Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Success Criteria:
Demonstrate with data conformance to success criteria standards as outlined in the technology transfer plan: Process parameters and control mechanisms Material suppliers Analytical methods Health, safety and environmental concerns Compliance with all registered commitments

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

There Is More To Successful Technology Transfer:


Technology Transfer must also be completed: Safely The process being transferred runs as expected (yield, purity, cycle time, etc.) On time (product launch) On budget No CRISIS situations

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Critical Success Factors Post Approval :


Change Control Audit process performance
Statistical review

Continual process improvement program


Statistical process control

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

If technology transfer isnt done right


Process validation may be unsuccessful Delayed regulatory approval and/or product launch Flawed processing may result
High rate of batch rejections, costly schedule revisions, excessive labour requirements

Analytical methods cannot support production Incomplete documentation Product does not perform as intended!

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Keys to Success

What Is the Key to Successful Knowledge Transfer? It Must Be Understood and Managed by ALL Stakeholders

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Keys to Success

Communication
Open communication between all team members Direct communication between technical members Effective and timely communication with regulators

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Keys to Success

Communication
Cultural / Organizational Differences
Germany

Austria

Switzerland

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Sending and Receiving Unit


Technology transfer is not a one way street. The sending unit and receiving unit must be equally involved in the process to ensure success.
Formulation Development Analytical Development

Process Development

Quality Control

Technical Services

Production

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Team work, most of the time

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Technology Transfer Success Criteria

Effective technology transfer is critical to success in pharmaceutical industry

Regulators

Regulators

APPROVAL

Involvement

Development

Post Approval

Commercial

Project Conception
Regulatory Bodies

Research and Development

Commercial Operations

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

Thank You

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

References
1. ISPE Technology Transfer Guide, 2003 2. F. Sexton, Effective and Efficient Knowledge Transfer from R&D to Manufacturing, Purdue Pharmas SMC Meeting, March 2004 3. G. Millili, Ph. D, Technology Transfer: Manufacturing Perspective, Pharm Tech Conference 1996 4. S. Liebowitz, Ph. D, Pharmaceutical Technology Transfer: Pre and Post NDA Submission, Pharm Tech Conference 1995

Joint CVG/Therapeutic Products Directorate International Convention and Exhibition, Toronto, Canada, October 5 - 6, 2006

You might also like